These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28094819)

  • 1. Age-dependent concomitant changes in synaptic dysfunction and GABAergic pathway in the APP/PS1 mouse model.
    Oyelami T; Bondt A; den Wyngaert IV; Hoorde KV; Hoskens L; Shaban H; Kemp JA; Drinkenburg WH
    Acta Neurobiol Exp (Wars); 2016; 76(4):282-293. PubMed ID: 28094819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
    Gelman S; Palma J; Tombaugh G; Ghavami A
    J Alzheimers Dis; 2018; 61(1):195-208. PubMed ID: 29154272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
    Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
    CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related synaptic dysfunction in Tg2576 mice starts as a failure in early long-term potentiation which develops into a full abolishment of late long-term potentiation.
    Fernández-Fernández D; Dorner-Ciossek C; Kroker KS; Rosenbrock H
    J Neurosci Res; 2016 Mar; 94(3):266-81. PubMed ID: 26629777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
    Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
    Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
    Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
    Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
    Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
    Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
    Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer's Disease Model.
    Cheng A; Wang J; Ghena N; Zhao Q; Perone I; King TM; Veech RL; Gorospe M; Wan R; Mattson MP
    J Neurosci; 2020 Jan; 40(3):694-709. PubMed ID: 31818974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion of CB
    Aso E; Andrés-Benito P; Ferrer I
    Biochem Pharmacol; 2018 Nov; 157():210-216. PubMed ID: 30096288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
    Hsiao YH; Kuo JR; Chen SH; Gean PW
    Neurobiol Dis; 2012 Mar; 45(3):1111-20. PubMed ID: 22227002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?
    Marchetti C; Marie H
    Rev Neurosci; 2011; 22(4):373-402. PubMed ID: 21732714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in the neuronal surface of post and presynaptic GABA
    Martín-Belmonte A; Aguado C; Alfaro-Ruíz R; Moreno-Martínez AE; de la Ossa L; Martínez-Hernández J; Buisson A; Früh S; Bettler B; Shigemoto R; Fukazawa Y; Luján R
    Brain Pathol; 2020 May; 30(3):554-575. PubMed ID: 31729777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
    Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
    Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamics.
    Ricoy UM; Mao P; Manczak M; Reddy PH; Frerking ME
    Neurosci Lett; 2011 Aug; 500(3):212-5. PubMed ID: 21741442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.